Why the study?
How do sublingual nitroglycerin and intravenous propranolol affect right ventricular fiber shortening and hemodynamics in patients with and without coronary artery disease?
How do sublingual nitroglycerin and intravenous propranolol affect right ventricular fiber shortening and hemodynamics in patients with and without coronary artery disease?
Answers are grounded in this paper and cite their sources.
Nitroglycerin and propranolol have distinct and sometimes opposing acute hemodynamic and metabolic effects on the myocardium in patients with and without coronary artery disease.
The action of sublingual nitroglycerin (0.6 mg) and intravenous propranolol (0.1 mg/kg) on shortening of right ventricular fibers was investigated in patients with and without coronary artery disease. This was accomplished with a newly devised strain gauge catheter. Hemodynamic parameters and changes in the oxidation-reduction potential of heart muscle were determined. Nitroglycerin results in decrease in shortening and velocity of shortening of ventricular fibers, heart rate, left ventricular end-diastolic and systemic pressure, dp/dt, tension-time index, stroke index, peripheral resistance, and left ventricular minute work in normal and arteriosclerotic subjects. Intravenous propranolol leads to a fall in velocity of shortening of myocardial fibers, heart rate, dp/dt, stroke index, and left ventricular minute work. However, there is an increase in tension-time index and peripheral resistance with no change in systemic pressure. Left ventricular end-diastolic pressure rises significantly in arteriosclerotic patients. The myocardial oxidation-reduction potential increases after nitroglycerin whereas it falls after propranolol in normal and arteriosclerotic patients.
No takes yet. Share an insight, caveat, or question.
Robin et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: